Dr. Michael J. Balick, an Associate Editor of The Joumal of Alternative and Complementary Medicine, Has Been Elected an AAAS Fellow

2000 ◽  
Vol 6 (1) ◽  
pp. 97-97
Author(s):  
JoAnn Gutin
Author(s):  
Brenda L. Lovell ◽  
Jamileh Daneshnia ◽  
Christopher J. Fries

2021 ◽  
Vol 2 (1) ◽  
pp. 28
Author(s):  
Saras Jyoti ◽  
Ram Gopal Parihar ◽  
Ajay Gandhi

Background: Neurotherapy is an alternative and complementary medicine originated in India. It is drugless holistic treatment founded and developed by Sh. Lajpatrai Mehra respectfully called “Guruji” by using ancient knowledge of ‘Nadi Vigyan’ (knowledge of nervous system), Ayureveda and principles of Anatomy and Physiology. Summary: t uses the finding of medical physiology but views them from a uniquely and refreshing approach, one that negates the use of medicines or drugs. Supported by basis of physiology, Dr. Lajpatrai Mehra (Guruji) has combined these palpations with symptoms and related them with various health conditions. Key message: The therapy acts on root-cause of the disease. It uncovers the root cause of the disease and cures the same in a sophisticated manner without the use of drugs or medication. It is simple therapy with potential to normalize or revive the functioning of the organs


2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Barbara Pickut ◽  
Sven Vanneste ◽  
Mark A. Hirsch ◽  
Wim Van Hecke ◽  
Eric Kerckhofs ◽  
...  

Objective. To investigate possible neurobehavioral changes secondary to a mindfulness based intervention (MBI) training for individuals living with Parkinson’s disease (PD).Background. In the context of complementary medicine, MBIs are increasingly being used for stress reduction and in patient populations coping with chronic illness. The use of alternative and complementary medicine may be higher in patients with chronic conditions such as PD. However, behavioral effects of mindfulness training in PD have not yet been reported in the literature and this points to an unmet need and warrants further examination.Methods. A total of 27 out of 30 PD patients completed a randomized controlled longitudinal trial. Questionnaires and the UPDRS I–IV were obtained at baseline and 8-week follow-up.Results. Significant changes after the MBI were found including a 5.5 point decrease on the UPDRS motor score, an increase of 0.79 points on Parkinson’s disease questionnaire (PDQ-39) pain item, and a 3.15 point increase in the Five Facet Mindfulness Questionnaire observe facet.Conclusions. To the best of our knowledge, this is the first quantitative analysis of neurobehavioral effects of MBI in PD.


Sign in / Sign up

Export Citation Format

Share Document